Trial Profile
A Phase 4, Open Label Study To Assess The Bronchopulmonary Pharmacokinetics Of Anidulafungin And Voriconazole Following Intravenous Administration In Healthy Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Anidulafungin (Primary) ; Voriconazole (Primary)
- Indications Aspergillosis; Candidaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 14 May 2014 New trial record